Depression, Infectious Pathogens and subclinical Coronary Artery Disease (CAD)
抑郁症、传染性病原体和亚临床冠状动脉疾病 (CAD)
基本信息
- 批准号:7338340
- 负责人:
- 金额:$ 11.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-01 至 2009-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibodiesArchivesAreaBeck depression inventoryBrothersCardiovascular DiseasesCardiovascular systemClassClinicalCoronaryCoronary ArteriosclerosisCoronary heart diseaseDNADSM-IVData AnalysesDepressed moodDevelopmentDevelopment PlansDiagnosisDisease regressionDoctor of PhilosophyEducational workshopEnzyme-Linked Immunosorbent AssayEpidemiologic StudiesEpidemiologyExposure toFosteringFundingFutureGenesGeneticGenetic PolymorphismGoalsHamilton Rating Scale for DepressionHealthHeartHeart failureImmune systemIncidenceIndividualInfectionInflammatoryInternal MedicineInterviewInvestigationKnowledgeLeadLearningLifeLife StyleLinkLiteratureMajor Depressive DisorderManuscriptsMeasuresMediatingMedicineMental DepressionMethodsNumbersParticipantPersonalityPersonsPositron-Emission TomographyProcessPsychologyPublishingResearchResearch DesignResearch PersonnelResearch Project GrantsRiskRisk FactorsSamplingSocioeconomic StatusStructureThickTrainingTwin Multiple BirthUltrasonographyWritingbasebrachial arterycareerdesigndisorder riskinstrumentinterestintima mediamalemenmiddle agepathogenpathogen exposurepatient oriented researchprofessorskillssubclinical depression
项目摘要
DESCRIPTION (provided by applicant):
Candidate: The candidate is an Assistant Professor of Medicine with a Ph.D. in epidemiology. He has exceptionally strong skills in the areas of study design, data analysis, and manuscript writing. He has had a longstanding interest in how depression affects cardiovascular health, and was lead author of a recent study of depression and incident heart failure that was published in the Archives of Internal Medicine. The candidate's immediate career goals are twofold: (1)Conduct a study which examines whether infectious pathogens mediate the link between depression and coronary artery disease (CAD), and (2)Enhance his research skills in ways that will foster his ability conduct future studies of depression and CAD. His long term career goal is to become an independent investigator conducting patient-oriented studies of depression and cardiovascular disease.
Research Career Development Plan: The candidate intends to pursue a number of career development activities. The two most important activities will be as follows: (1)He will receive training in how to administer instruments designed to measure depression. These instruments will include the Structured Clinical Interview for DSM-IV (SCID) as well as the Hamilton Depression Scale (HAMD). After receiving sufficient training, the candidate will administer these instruments to participants in his study. (2)The candidate will acquire further knowledge in the area of personality and psychology and will develop skills in the area of statistical genetics. This will be accomplished by attending seminars, workshops, and classes.
Research Project: The specific aim of the candidate's research project is to examine whether the association between depression and subclinical CAD is mediated by infectious pathogens. His project will be a substudy of an existing NHLBI-funded investigation ("The Twins Heart Study"). His project will be based on a sample of 80 male-male twin pairs. Depression will be assessed by the SCID, HAMD, and the Beck Depression Inventory. Seropositivity to antibodies of a variety of infectious pathogens will be assessing by ELISA methods. Subclinical measures of CAD will include coronary flow reserve (assessed by PET), carotid intima-media thickness (assessed by ultrasound), and flow-mediated dilation of the brachial artery (assessed by ultrasound). Random effects regression methods will be used to determine if depression is associated with infectious pathogen exposure and whether such an association explains the link between depression and subclinical CAD.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEROME L. ABRAMSON其他文献
JEROME L. ABRAMSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEROME L. ABRAMSON', 18)}}的其他基金
Melatonin and Nighttime Blood Pressure in African Americans
非裔美国人的褪黑激素和夜间血压
- 批准号:
7661116 - 财政年份:2009
- 资助金额:
$ 11.88万 - 项目类别:
Melatonin and Nighttime Blood Pressure in African Americans
非裔美国人的褪黑激素和夜间血压
- 批准号:
7845246 - 财政年份:2009
- 资助金额:
$ 11.88万 - 项目类别:
CD40 LIGAND AS ADJUVANT FOR RAISING PROTECTIVE ANTI-HIV AB BY DNA/MVA VACCINES
CD40 配体作为 DNA/MVA 疫苗产生保护性抗 HIV AB 的佐剂
- 批准号:
7562678 - 财政年份:2007
- 资助金额:
$ 11.88万 - 项目类别:
OAR FUNDING FOR ENHANCEMENT OF FACILITIES FOR AIDS RELATED RESEARCH
OAR 为加强艾滋病相关研究设施提供资金
- 批准号:
7562689 - 财政年份:2007
- 资助金额:
$ 11.88万 - 项目类别:
OXIDATIVE STRESS AS A PREDICTOR OF BLOOD PRESSURE CHANGES OVER TIME
氧化应激作为血压随时间变化的预测因子
- 批准号:
7603619 - 财政年份:2006
- 资助金额:
$ 11.88万 - 项目类别:
OXIDATIVE STRESS AS A PREDICTOR OF BLOOD PRESSURE CHANGES
氧化应激作为血压变化的预测因子
- 批准号:
7376372 - 财政年份:2005
- 资助金额:
$ 11.88万 - 项目类别:
Depression, Infectious Pathogens and subclinical Coronary Artery Disease (CAD)
抑郁症、传染性病原体和亚临床冠状动脉疾病 (CAD)
- 批准号:
7163514 - 财政年份:2005
- 资助金额:
$ 11.88万 - 项目类别:
OXIDATIVE STRESS AS A PREDICTOR OF BLOOD PRESSURE CHANGES OVER TIME
氧化应激作为血压随时间变化的预测因子
- 批准号:
7198950 - 财政年份:2005
- 资助金额:
$ 11.88万 - 项目类别:
Depression,Infectious Pathogens, and subclinical CAD
抑郁症、传染性病原体和亚临床 CAD
- 批准号:
7011266 - 财政年份:2005
- 资助金额:
$ 11.88万 - 项目类别:
Depression, Infectious Pathogens, and subclinical CAD
抑郁症、传染性病原体和亚临床 CAD
- 批准号:
6860922 - 财政年份:2005
- 资助金额:
$ 11.88万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 11.88万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 11.88万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 11.88万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 11.88万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 11.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 11.88万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 11.88万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 11.88万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 11.88万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 11.88万 - 项目类别: